675 filings
Page 6 of 34
8-K
zdvtyh3l909sn
23 Mar 21
Departure of Directors or Certain Officers
4:05pm
8-K
9ggukvc 9m
12 Feb 21
Regulation FD Disclosure
11:36am
8-K
0330s
1 Feb 21
Departure of Directors or Certain Officers
4:05pm
8-K
lc1zrzou f0
25 Jan 21
Clinical trial amendment successfully completed for co-primary endpoints
7:35am
8-K
mdjie
17 Nov 20
Departure of Directors or Certain Officers
5:28pm
8-K
5htxwieclg co6ctrn7
12 Nov 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
7syhemxpg5egr05p8
9 Nov 20
Abeona Therapeutics Reports Third Quarter Financial Results
4:42pm
8-K
iz66msr
30 Oct 20
Abeona Therapeutics Announces the Appointment of Michael Amoroso as Chief Operating Officer
4:05pm
8-K
sutvbl3 ngt
16 Oct 20
Entry into a Material Definitive Agreement
4:15pm
8-K
j98b1k oh
6 Oct 20
Abeona Therapeutics’ Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership Plan
4:37pm
8-K
09aq 7m5zt
29 Sep 20
Abeona Therapeutics Announces Leadership and Board Transitions
4:35pm
8-K
m7zevkbtb9mqd rxz2t
17 Sep 20
Departure of Directors or Certain Officers
9:11am
8-K
gr5wot 9ako
10 Aug 20
Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates
4:33pm
8-K
myfo64 t4te
23 Jun 20
Abeona Therapeutics Further Strengthens Board with Appointment of Two New Independent Directors
4:35pm
S-8
uow78et5k8k
21 May 20
Registration of securities for employees
4:42pm
8-K
quk1jid76xjof5
21 May 20
Departure of Directors or Certain Officers
4:38pm
8-K
54cwm321pwnll
6 May 20
Abeona Therapeutics Reports First Quarter Financial Results and Business Updates
4:25pm